An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Quanterix Corporation (NASDAQ: QTRX) announced it will release its third quarter 2021 financial results on November 4, 2021, after market close. A conference call hosted by CEO Kevin Hrusovsky will follow at 4:30 p.m. EDT to discuss the results and provide a business update. Interested parties can join the call via phone or livestream. Quanterix aims to digitize biomarker analysis to enhance precision health, focusing on earlier disease detection and improved treatment methods across various therapeutic areas.
Positive
Company aims to advance precision health through digital biomarker analysis.
Simoa technology may enhance early disease detection across multiple therapeutic areas.
Negative
None.
BILLERICA, Mass.--(BUSINESS WIRE)--
Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will release its financial results for third quarter 2021 after the close of trading on Nov. 4, 2021. Company management will host a conference call at 4:30 p.m. EDTto discuss Quanterix’ financial results and provide a business update. The call will be hosted by Kevin Hrusovsky, Chairman and Chief Executive Officer, Quanterix.
Individuals interested in listening to the conference call may do so by dialing (833) 686-9351 for domestic callers, or (612) 979-9890 for international callers. Please reference the following conference ID: 3488875. A live webcast will also be available at: https://edge.media-server.com/mmc/p/bpkzrdsj. The webcast will be available on the Company’s website, http://www.quanterix.com, for one year following completion of the call.
To access the live webcast of Quanterix' presentations, please visit the News & Events page within the Investors section of the Quanterix website at http://www.quanterix.com. Replays of the webcasts will be available on the Quanterix website for 90 days following the conference.
About Quanterix Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts. For additional information, please visit https://www.quanterix.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this news release are based on Quanterix’ expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause Quanterix’ actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Quanterix’ filings with the U.S. Securities and Exchange Commission, including the "Risk Factors" sections contained therein. Except as required by law, Quanterix assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.
When will Quanterix release its Q3 2021 financial results?
Quanterix Corporation will release its Q3 2021 financial results on November 4, 2021, after market close.
What time is Quanterix's Q3 2021 conference call?
The conference call to discuss Quanterix's Q3 2021 financial results will take place at 4:30 p.m. EDT on November 4, 2021.
Who is hosting the Quanterix Q3 2021 results call?
The Q3 2021 results call will be hosted by Kevin Hrusovsky, Chairman and CEO of Quanterix.
How can I access the Quanterix conference call?
To access the Quanterix conference call, dial (833) 686-9351 for domestic calls or (612) 979-9890 for international calls, referencing conference ID 3488875, or join via the live webcast available on Quanterix's website.
What is the focus of Quanterix's technology?
Quanterix's technology focuses on digitizing biomarker analysis to enable earlier disease detection and improved prognoses in various therapeutic areas including oncology and neurology.
